Within-person variation in the postprandial lipemic response of healthy adults

American Journal of Clinical Nutrition

Volumn 97, Issue 2, 2013, Pages 261-267

  Ryan, Miriam F ^a   Grada, Colm O ^a   Morris, Ciara ^a   Segurado, Ricardo ^a   Walsh, Marianne C ^a   Gibney, Eileen R ^a   Brennan, Lorraine ^a   Roche, Helen M ^a   Gibney, Michael J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY COMPOSITION; BODY MASS; DIET RESTRICTION; FAT INTAKE; FAT TOLERANCE TEST; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MALE; NORMAL HUMAN; PHENOTYPIC VARIATION; PHYSICAL PERFORMANCE; POSTPRANDIAL STATE; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; COHORT STUDIES; DIET, HIGH-FAT; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; INTERLEUKINS; IRELAND; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; RECEPTORS, CCR1; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; YOUNG ADULT;

EID: 84873340850     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.047936     Document Type: Article

References (48)

1. Lambert JE, Parks EJ. Postprandial metabolism of meal triglyceride in humans. Biochim Biophys Acta 2012; 1821: 721-6.
2. Boullart AC, de Graaf J, Stalenhoef AF. Serum triglycerides and risk of cardiovascular disease. Biochim Biophys Acta 2012; 1821: 867-75.
3. Labreuche J, Deplanque D, Touboul PJ, Bruckert E, Amarenco P. Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis 2010; 212: 9-15.
4. Roche HM, Gibney MJ. The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 2000; 7: 317-24.
5. Jackson KG, Poppitt SD, Minihane AM. Postprandial lipemia and cardiovascular disease risk: interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 2012; 220: 22-33.
6. Krug S, Kastenmüller G, Stückler F, Rist MJ, Skurk T, Sailer M, Raffler J, Römisch-Margl W, Adamski J, Prehn C, et al. The dynamic range of the human metabolome revealed by challenges. FASEB J 2012; 26: 2607-19.
7. Zivkovic AM, Wiest MM, Nguyen U, Nording ML, Watkins SM, German JB. Assessing individual metabolic responsiveness to a lipid challenge using a targeted metabolomic approach. Metabolomics 2009; 5: 209-18.
8. López-Miranda J, Pérez-Martínez P, Marín C, Moreno JA, Gómez P, Pérez-Jiménez F. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr Opin Lipidol 2006; 17: 132-8.
9. Burdge GC, Jones AE, Frye SM, Goodson L, Wootton SA. Effect of meal sequence on postprandial lipid, glucose and insulin responses in young men. Eur J Clin Nutr 2003; 57: 1536-44.
10. Weiss EP, Fields DA, Mittendorfer B, Haverkort MA, Klein S. Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test. Metabolism 2008; 57: 1479-85.
11. Gill JM, Malkova D, Hardman AE. Reproducibility of an oral fat tolerance test is influenced by phase of menstrual cycle. Horm Metab Res 2005; 37: 336-41.
12. Brown SA, Chambless LE, Sharrett AR, Gotto AM Jr, Patsch W. Postprandial lipemia: reliability in an epidemiologic field study. Am J Epidemiol 1992; 136: 538-45.
13. Merrill JR, Holly RG, Anderson RL, Rifai N, King ME, DeMeersman R. Hyperlipemic response of young trained and untrained men after a high fat meal. Arteriosclerosis 1989; 9: 217-23.
14. Gaenzer H, Sturm W, Neumayr G, Kirchmair R, Ebenbichler C, Ritsch A, Föger B, Weiss G, Patsch JR. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res 2001; 52: 509-16.
15. Pedrini MT, Niederwanger A, Kranebitter M, Tautermann C, Ciardi C, Tatarczyk T, Patsch JR. Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia 2006; 49: 1612-8.
16. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Nutrigenetics of the postprandial lipoprotein metabolism: evidences from human intervention studies. Curr Vasc Pharmacol 2011; 9: 287-91.
17. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ 1996; 312: 935-9.
18. Lozano A, Perez-Martinez P, Delgado-Lista J, Marin C, Cortes B, Rodriguez-Cantalejo F, Gomez-Luna MJ, Cruz-Teno C, Perez-Jimenez F, Lopez-Miranda J. Body mass interacts with fat quality to determine the postprandial lipoprotein response in healthy young adults. Nutr Metab Cardiovasc Dis 2012; 22: 355-61.
19. Hitze B, Rubin D, Helwig U, Schrezenmeir J, Bosy-Westphal A, Müller MJ. Postprandial triglyceride response in men: role of overweight, abdominal fat and nutrition. Obes Facts 2008; 1: 45-51.
20. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Hoursalas IS, Mikhailidis DP, Cokkinos DV. Metabolic syndrome and gender differences in postprandial lipaemia. Eur J Cardiovasc Prev Rehabil 2006; 13: 661-4.
21. Jackson KG, Knapper-Francis JM, Morgan LM, Webb DH, Zampelas A, Williams CM. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men. Clin Sci (Lond) 2003; 105: 457-66.
22. van Oostrom AJ, Alipour A, Sijmonsma TP, Verseyden C, Dallinga-Thie GM, Plokker HW, Castro Cabezas M. Comparison of different methods to investigate postprandial lipaemia. Neth J Med 2009; 67: 13-20.
23. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007; 98: 458-73.
24. Mekki N, Christofilis MA, Charbonnier M, Atlan-Gepner C, Defoort C, Juhel C, Borel P, Portugal H, Pauli AM, Vialettes B, et al. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 1999; 84: 184-91.
25. Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, Parnell LD, Garcia-Rios A, Ordovas JM, Lopez-Miranda J. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J Lipid Res 2010; 51: 63-73.
26. Perez-Martinez P, Deldago-Lista J, Jiminez FP, Lopez-Miranda J. Update on genetics of postprandial lipemia. Atherosclerosis 2010; 11: 39-43.
27. Compher C, Frankenfield D, Keim N, Roth-Yousey L, Evidence Analysis Working Group. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc 2006; 106: 881-903.
28. Denis R, Wilkinson J, De Vito G. Influence of angular velocity on vastus lateralis and rectus femoris oxygenation dynamics during knee extension exercises. Clin Physiol Funct Imaging 2011; 31: 352-7.
29. Chan DC, Watts GF, Barrett PH, Mamo JC, Redgrave TG. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem 2002; 48: 278-83.
30. Jong MC, Havekes LM. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice. Int J Tissue React 2000; 22: 59-66.
31. Ooi EM, Barrett PH, Chan DC, Watts GF. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci (Lond) 2008; 114: 611-24.
32. Onat A, Hergenç G, Sansoy V, Fobker M, Ceyhan K, Toprak S, Assmann G. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 2003; 168: 81-9.
33. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M, Asia Pacific Cohort Studies Collaboration. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004; 110: 2678-86.
34. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Castro Cabezas M. Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 2008; 9: 39-44.
35. Patsch W, Esterbauer H, Föger B, Patsch JR. Postprandial lipemia and coronary risk. Curr Atheroscler Rep 2000; 2: 232-42.
36. Robertson MD, Henderson RA, Vist GE, Rumsey RD. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am J Clin Nutr 2002; 75: 505-10.
37. Ordovás JM, Robertson R, Cléirigh EN. Gene-gene and gene-environment interactions defining lipid-related traits. Curr Opin Lipidol 2011; 22: 129-36.
38. Goulart AC, Rexrode KM, Cheng S, Rose L, Buring JE, Ridker PM, Zee RY. Association of genetic variants with the metabolic syndrome in 20,806 white women: the Women's Health Genome Study. Am Heart J 2009; 158: 257-62.
39. Carter KW, Hung J, Powell BL, Wiltshire S, Foo BT, Leow YC, McQuillan BM, Jennens M, McCaskie PA, Thompson PL, et al. Association of interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population. Hum Genet 2008; 124: 199-206.
40. Luotola K, Pääkkönen R, Alanne M, Lanki T, Moilanen L, Surakka I, Pietilä A, Kähönen M, Nieminen MS, Kesäniemi YA, et al. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab 2009; 94: 4575-83.
41. Weyrich P, Staiger H, Stancáková A, Machicao F, Machann J, Schick F, Stefan N, Kuusisto J, Laakso M, Schäfer S, et al. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM studies. PLoS ONE 2010; 5:e13980.
42. Cuda C, Badawi A, Karmali M, El-Sohemy A. Polymorphisms in Tolllike receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 2011; 60: 1131-5.
43. Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J Nutr Biochem 2012; 23: 239-44.
44. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjögren M, Ling C, Eriksson KF, Lethagen AL, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-63.
45. Vaxillaire M, Veslot J, Dina C, Proença C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, et al.; DESIR Study Group. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2008; 57: 244-54.
46. Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther 2009; 124: 44-56.
47. Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics 2002; 12: 23-30.
48. Phillips CM, Goumidi L, Bertrais S, Field MR, Peloso GM, Shen J, McManus R, Hercberg S, Lairon D, Planells R, et al. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. J Nutr 2009; 139: 2011-7.